WSO - June 2023 - 510

510
International Journal of Stroke 18(5)
Table 2. (Continued)
Recommendations
Blood pressure targets
The target blood pressure for patients with stroke or TIA is < 130/80 mm Hg
Weight
In patients with ischemic stroke or TIA, it is recommended to estimate the BMI at the
time of the event and during long-term follow-up
In patients with ischemic stroke or TIA who are overweight or obese, weight loss is
recommended
In patients with ischemic stroke or TIA who are obese, referral to a multidisciplinary
lifestyle modification program is recommended
Diabetes
In patients with ischemic stroke or TIA and diabetes, a target of HbA1c ⩽ 7% is
recommended
In patients with ischemic stroke or TIA and diabetes, the treatment of diabetes should
include glucose-lowering agents with demonstrated efficacy for reducing vascular
outcomes
In patients with ischemic stroke or TIA and diabetes, a transdisciplinary team approach is
recommended
Lipids
Ischemic stroke and TIA patients without a proven cardioembolic mechanism and an LDLcholesterol
level > 2.5 mmol/L (> 100 mg/dL) should receive atorvastatin 80 mg to reduce
stroke recurrence
The target LDL-cholesterol level in patients with ischemic stroke and TIA should be < 1.8
mmol/L (70 mg/dL)
The target LDL-cholesterol level in patients with ischemic stroke and TIA and
atherosclerotic disease of the extracranial or intracranial arteries should be 1.8 mmol/L
(70 mg/dL). Ezetimibe can be added to Atorvastatin to reach this goal
In patients with ischemic stroke or TIA in whom a target LDL-cholesterol level is not
achievable, a consideration should be made to refer to an expert in lipid management for
adding a PCSK9 inhibitor
In patients with ischemic stroke or TIA on lipid-lowering medications, lipid levels should
be monitored 1-3 months after treatment initiation, followed by regular assessments and
dose adjustments every 3-12 months thereafter
Lifestyle modification
Physical activity
In patients with ischemic stroke or TIA who can engage in physical activity, low/moderateintensity
aerobic activity for 10 min 4 days/week, or vigorous aerobic activity for 20 min
twice a week is recommended
Smoking cessation
In patients with ischemic stroke or TIA, smoking status should be evaluated and
documented in all health care encounters
√
√
√
(Continued)
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
Minimal
Essential
Advanced
International Journal of Stroke, 18(5)

WSO - June 2023

Table of Contents for the Digital Edition of WSO - June 2023

Contents
WSO - June 2023 - Cover1
WSO - June 2023 - Cover2
WSO - June 2023 - 491
WSO - June 2023 - Contents
WSO - June 2023 - 493
WSO - June 2023 - 494
WSO - June 2023 - 495
WSO - June 2023 - 496
WSO - June 2023 - 497
WSO - June 2023 - 498
WSO - June 2023 - 499
WSO - June 2023 - 500
WSO - June 2023 - 501
WSO - June 2023 - 502
WSO - June 2023 - 503
WSO - June 2023 - 504
WSO - June 2023 - 505
WSO - June 2023 - 506
WSO - June 2023 - 507
WSO - June 2023 - 508
WSO - June 2023 - 509
WSO - June 2023 - 510
WSO - June 2023 - 511
WSO - June 2023 - 512
WSO - June 2023 - 513
WSO - June 2023 - 514
WSO - June 2023 - 515
WSO - June 2023 - 516
WSO - June 2023 - 517
WSO - June 2023 - 518
WSO - June 2023 - 519
WSO - June 2023 - 520
WSO - June 2023 - 521
WSO - June 2023 - 522
WSO - June 2023 - 523
WSO - June 2023 - 524
WSO - June 2023 - 525
WSO - June 2023 - 526
WSO - June 2023 - 527
WSO - June 2023 - 528
WSO - June 2023 - 529
WSO - June 2023 - 530
WSO - June 2023 - 531
WSO - June 2023 - 532
WSO - June 2023 - 533
WSO - June 2023 - 534
WSO - June 2023 - 535
WSO - June 2023 - 536
WSO - June 2023 - 537
WSO - June 2023 - 538
WSO - June 2023 - 539
WSO - June 2023 - 540
WSO - June 2023 - 541
WSO - June 2023 - 542
WSO - June 2023 - 543
WSO - June 2023 - 544
WSO - June 2023 - 545
WSO - June 2023 - 546
WSO - June 2023 - 547
WSO - June 2023 - 548
WSO - June 2023 - 549
WSO - June 2023 - 550
WSO - June 2023 - 551
WSO - June 2023 - 552
WSO - June 2023 - 553
WSO - June 2023 - 554
WSO - June 2023 - 555
WSO - June 2023 - 556
WSO - June 2023 - 557
WSO - June 2023 - 558
WSO - June 2023 - 559
WSO - June 2023 - 560
WSO - June 2023 - 561
WSO - June 2023 - 562
WSO - June 2023 - 563
WSO - June 2023 - 564
WSO - June 2023 - 565
WSO - June 2023 - 566
WSO - June 2023 - 567
WSO - June 2023 - 568
WSO - June 2023 - 569
WSO - June 2023 - 570
WSO - June 2023 - 571
WSO - June 2023 - 572
WSO - June 2023 - 573
WSO - June 2023 - 574
WSO - June 2023 - 575
WSO - June 2023 - 576
WSO - June 2023 - 577
WSO - June 2023 - 578
WSO - June 2023 - 579
WSO - June 2023 - 580
WSO - June 2023 - 581
WSO - June 2023 - 582
WSO - June 2023 - 583
WSO - June 2023 - 584
WSO - June 2023 - 585
WSO - June 2023 - 586
WSO - June 2023 - 587
WSO - June 2023 - 588
WSO - June 2023 - 589
WSO - June 2023 - 590
WSO - June 2023 - 591
WSO - June 2023 - 592
WSO - June 2023 - 593
WSO - June 2023 - 594
WSO - June 2023 - 595
WSO - June 2023 - 596
WSO - June 2023 - 597
WSO - June 2023 - 598
WSO - June 2023 - 599
WSO - June 2023 - 600
WSO - June 2023 - 601
WSO - June 2023 - 602
WSO - June 2023 - 603
WSO - June 2023 - 604
WSO - June 2023 - 605
WSO - June 2023 - 606
WSO - June 2023 - 607
WSO - June 2023 - 608
WSO - June 2023 - 609
WSO - June 2023 - 610
WSO - June 2023 - 611
WSO - June 2023 - 612
WSO - June 2023 - 613
WSO - June 2023 - 614
WSO - June 2023 - 615
WSO - June 2023 - 616
WSO - June 2023 - 617
WSO - June 2023 - 618
WSO - June 2023 - 619
WSO - June 2023 - 620
WSO - June 2023 - 621
WSO - June 2023 - 622
WSO - June 2023 - 623
WSO - June 2023 - 624
WSO - June 2023 - 625
WSO - June 2023 - 626
WSO - June 2023 - Cover3
WSO - June 2023 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com